Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
iSpecimen
AddedFeb 19, 2024
UpdatedJun 18, 2026
iSpecimen

iSpecimen

Public

iSpecimen Inc.: A global tech firm offering an online marketplace for researchers and specimen contributors.

HQ
Lexington, MA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize the biospecimen procurement process, iSpecimen Inc. is a technology-driven company that connects researchers with specimen contributors through an innovative online marketplace. The company aims to streamline the acquisition and management of human biospecimens, thereby accelerating medical discoveries. iSpecimen offers a wide range of products, including diagnostic remnants, banked specimens, and prospective collections, catering to a global market of researchers and healthcare professionals.

Notable figures affiliated with iSpecimen include its leadership team and key investors who support its vision of transforming specimen procurement. The company has achieved significant milestones, such as building a diverse, global network of sample providers and facilitating numerous research projects worldwide. iSpecimen's impact lies in its ability to bring efficiency and innovation to an industry traditionally bogged down by logistical challenges, ultimately advancing medical research and discovery.

iSpecimen - Similar Companies

Scientist.com logo

Scientist.com

scientist.com

Labscoop logo

Labscoop

labscoop.com

Vivebio logo

Vivebio

Sanguine logo

Sanguine

sanguinebio.com

TriMetis Life Sciences logo

TriMetis Life Sciences

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

Zageno logo

Zageno

Conversant Bio logo

Conversant Bio

MolecularCloud logo

MolecularCloud

molecularcloud.org

Spot On Sciences logo

Spot On Sciences

spotonsciences.com

Labviva logo

Labviva

labviva.com

Global Registry of Biorepositories logo

Global Registry of Biorepositories

Science Exchange logo

Science Exchange

Insightful Science logo

Insightful Science

Biosurplus logo

Biosurplus

iSpecimen - Quick Facts

Who are iSpecimen's competitors?

Companies similar to iSpecimen include Scientist.com, Labscoop, Vivebio and Sanguine.

When was iSpecimen founded?

iSpecimen was founded in 2009.

Where is iSpecimen's headquarters located?

iSpecimen's headquarters is located in Lexington, MA, US.

When was iSpecimen's last funding round?

iSpecimen's most recent funding round was for $21M (USD) in November 2021.

How much has iSpecimen raised to-date?

As of Nov 28, 2021, iSpecimen has raised a total of $31M (USD).

How many employees does iSpecimen have?

iSpecimen has 75 employees as of Feb 6, 2024.

iSpecimen - Classification

Ownership
  • Public
Technology
  • Technology
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Biospecimens
Tags
  • Biotech
Unique IDs
  • ein: 270480143
  • secCik: 0001558569
  • ticker: ISPC
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 541713Research and Development in Nanotechnology
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified